What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING

Detalhes bibliográficos
Autor(a) principal: Becker, Ricardo G.
Data de Publicação: 2017
Outros Autores: Gregianin, Lauro J., Galia, Carlos R., Filho, Reynaldo Jesus-Garcia, Toller, Eduardo A., Badell, Gerardo, Nakagawa, Suely A., David, Alexandre, Baptista, André M., Yonamime, Eduardo S., Serafini, Osvaldo A., Penna, Valter [UNESP], Santos, Julie Francine C., Brunetto, Algemir L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/s12885-017-3391-5
http://hdl.handle.net/11449/175054
Resumo: Background: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.
id UNSP_20401a1eccda55b62ead01e7fb88471b
oai_identifier_str oai:repositorio.unesp.br:11449/175054
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWINGBone tumorsEwing sarcomaLocal controlOrthopedicsRadiation oncologySurgeryBackground: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.Service of Orthopedics and Traumatology Hospital de Clínicas de Porto Alegre (HCPA), Rua Ramiro Barcelos, 2350, Bairro Santa CeciliaDepartment of Pediatrics HCPA Universidade Federal do Rio Grande do Sul (UFRGS)Department of Pediatrics Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)Service of Orthopedics and Traumatology HCPASupport Group for Children and Adolescents with Cancer (GRAACC) Universidade Federal de São Paulo (UNIFESP)Fundação Pio XII Hospital de Câncer InfantojuvenilCentro Hospitalario Pereira RossellOrthopedics Service Hospital A.C. Camargo Cancer CenterService of Orthopedics and Traumatology Santa Casa de Misericórdia de Porto AlegreOrthopedic Trauma Institute Hospital das Clínicas de São Paulo School of Medicine Universidade de São Paulo (USP)Department of Orthopedics and Traumatology Santa Casa de Misericórdia de São Paulo (HSCSP)Service of Orthopedics and Traumatology Hospital São Lucas Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)Hospital das Clínicas deBotucatu School of Medicine Universidade Estadual Paulista (UNESP)Instituto do Câncer InfantilHospital das Clínicas deBotucatu School of Medicine Universidade Estadual Paulista (UNESP)Hospital de Clínicas de Porto Alegre (HCPA)Universidade Federal do Rio Grande do Sul (UFRGS)Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)HCPAUniversidade Federal de São Paulo (UNIFESP)Hospital de Câncer InfantojuvenilCentro Hospitalario Pereira RossellHospital A.C. Camargo Cancer CenterSanta Casa de Misericórdia de Porto AlegreUniversidade de São Paulo (USP)Santa Casa de Misericórdia de São Paulo (HSCSP)Universidade Estadual Paulista (Unesp)Instituto do Câncer InfantilBecker, Ricardo G.Gregianin, Lauro J.Galia, Carlos R.Filho, Reynaldo Jesus-GarciaToller, Eduardo A.Badell, GerardoNakagawa, Suely A.David, AlexandreBaptista, André M.Yonamime, Eduardo S.Serafini, Osvaldo A.Penna, Valter [UNESP]Santos, Julie Francine C.Brunetto, Algemir L.2018-12-11T17:14:01Z2018-12-11T17:14:01Z2017-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.1186/s12885-017-3391-5BMC Cancer, v. 17, n. 1, 2017.1471-2407http://hdl.handle.net/11449/17505410.1186/s12885-017-3391-52-s2.0-850275515612-s2.0-85027551561.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBMC Cancer1,464info:eu-repo/semantics/openAccess2023-12-07T06:19:16Zoai:repositorio.unesp.br:11449/175054Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-12-07T06:19:16Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
title What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
spellingShingle What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
Becker, Ricardo G.
Bone tumors
Ewing sarcoma
Local control
Orthopedics
Radiation oncology
Surgery
title_short What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
title_full What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
title_fullStr What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
title_full_unstemmed What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
title_sort What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group - EWING
author Becker, Ricardo G.
author_facet Becker, Ricardo G.
Gregianin, Lauro J.
Galia, Carlos R.
Filho, Reynaldo Jesus-Garcia
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, André M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter [UNESP]
Santos, Julie Francine C.
Brunetto, Algemir L.
author_role author
author2 Gregianin, Lauro J.
Galia, Carlos R.
Filho, Reynaldo Jesus-Garcia
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, André M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter [UNESP]
Santos, Julie Francine C.
Brunetto, Algemir L.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Hospital de Clínicas de Porto Alegre (HCPA)
Universidade Federal do Rio Grande do Sul (UFRGS)
Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
HCPA
Universidade Federal de São Paulo (UNIFESP)
Hospital de Câncer Infantojuvenil
Centro Hospitalario Pereira Rossell
Hospital A.C. Camargo Cancer Center
Santa Casa de Misericórdia de Porto Alegre
Universidade de São Paulo (USP)
Santa Casa de Misericórdia de São Paulo (HSCSP)
Universidade Estadual Paulista (Unesp)
Instituto do Câncer Infantil
dc.contributor.author.fl_str_mv Becker, Ricardo G.
Gregianin, Lauro J.
Galia, Carlos R.
Filho, Reynaldo Jesus-Garcia
Toller, Eduardo A.
Badell, Gerardo
Nakagawa, Suely A.
David, Alexandre
Baptista, André M.
Yonamime, Eduardo S.
Serafini, Osvaldo A.
Penna, Valter [UNESP]
Santos, Julie Francine C.
Brunetto, Algemir L.
dc.subject.por.fl_str_mv Bone tumors
Ewing sarcoma
Local control
Orthopedics
Radiation oncology
Surgery
topic Bone tumors
Ewing sarcoma
Local control
Orthopedics
Radiation oncology
Surgery
description Background: Relapse in localized Ewing sarcoma patients has been a matter of concern regarding poor prognosis. Therefore, we investigated the impact of local control modality (surgery, surgery plus radiotherapy, and radiotherapy) on clinical outcomes such as survival and recurrence in patients with non-metastatic Ewing sarcoma treated on the first Brazilian Collaborative Group Trial of the Ewing Family of Tumors (EWING1). Methods: Seventy-three patients with localized Ewing sarcoma of bone aged < 30 years were included. The treating physicians defined the modality of local control based on the recommendations of the coordinating center and the patient and tumor characteristics. Possible associations of local control modality with local failure (LF), disease-free survival (DFS), event-free survival (EFS), overall survival (OS), and clinical characteristics were analyzed. Results: Mean patient age was 12.8 years (range, 2 to 25 years) and median follow-up time was 4.5 years (range, 2. 3 to 6.7 years). Forty-seven patients underwent surgery, 13 received radiotherapy, and 13 received both. The 5-year EFS, OS, and DFS for all patients was 62.1%, 63.3%, and 73.1%, respectively. The 5-year cumulative incidence (CI) of LF was 7.6% for surgery, 11.1% for radiotherapy, and 0% for postoperative radiotherapy (PORT) (p = 0.61). The 5-year EFS was 71.7% for surgery, 30.8% for radiotherapy, and 64.1% for PORT (p = 0.009). Conclusions: There was a significant effect of local control modality on EFS and OS in the study. Surgery and PORT modalities yielded very close results. The group treated with radiotherapy alone had considerably worse outcomes. This may be confounded by greater risk factors in these patients. There was no significant effect of local control modality on the CI of LF and DFS.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
2018-12-11T17:14:01Z
2018-12-11T17:14:01Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/s12885-017-3391-5
BMC Cancer, v. 17, n. 1, 2017.
1471-2407
http://hdl.handle.net/11449/175054
10.1186/s12885-017-3391-5
2-s2.0-85027551561
2-s2.0-85027551561.pdf
url http://dx.doi.org/10.1186/s12885-017-3391-5
http://hdl.handle.net/11449/175054
identifier_str_mv BMC Cancer, v. 17, n. 1, 2017.
1471-2407
10.1186/s12885-017-3391-5
2-s2.0-85027551561
2-s2.0-85027551561.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv BMC Cancer
1,464
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1799965204549730304